Format

Send to

Choose Destination
See comment in PubMed Commons below
J Pediatr Orthop. 1988 Jan-Feb;8(1):71-2.

Is APD a promising drug in the treatment of severe osteogenesis imperfecta?

Author information

  • 1Service de Rhumatologie, Cliniques Universitaires U.C.L. de Mont-Godinne et St-Luc, Bruxelles, Belgique.

Abstract

The efficacy of (3-amino-1-hydroxypropylidene)-1,1-biphosphonate (APD) is reported in a severe case of osteogenesis imperfecta (OI). An increased density at the metaphysis level is demonstrated on wrist radiograph. Similar findings have been observed in two other children with OI at various metaphyseal levels (e.g., tibia, femur). To our knowledge, this is the first time the effect of APD in children with severe OI has been reported.

PMID:
3335625
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk